Literature DB >> 18589091

Expression of the CXC chemokine receptor 3 and its ligands in ischemia-reperfusion injury of liver in rats.

Z Liu1, W Xu, X Zhang, D Cui, B Liu.   

Abstract

OBJECTIVE: To explore the expression of the CXC chemokine receptor 3 (CXCR3) and its ligands (IP-10, Mig) in ischemiareperfusion (I/R) injury of rat livers.
METHODS: Thirty-two Wistar rats were randomly divided into four groups with eight rats in each group: sham operation (SO) and 6-, 12-, or 24-hour I/R groups. The levels of tumor necrosis factor-alpha (TNF-alpha) in liver tissues were measured by enzyme-linked immunosorbent assay. The expressions of CXCR3 and its ligands (IP-10, Mig) were detected by semiquantitative reverse-transcriptase polymerase chain reaction. The serum levels of alanine transferase and aspartate transferase were also measured.
RESULTS: Low expressions of CXCR3, IP-10, and Mig mRNA were determined in the SO group. The expressions of CXCR3 and IP-10 mRNA in the ischemic tissue of the I/R group were significantly greater than those in the SO group (P < .01). The expressions of CXCR3 and IP-10 mRNA of the ischemic tissue in the 6-hour I/R group were higher than those in the 12-hour I/R group (P < .01). There was no difference in the levels of Mig mRNA between the I/R and SO groups. Compared with the SO group, the level of TNF-alpha was significantly increased in the I/R group, reaching its peak at reperfusion 12 hour.
CONCLUSION: The mRNA expressions of CXCR3 and its ligand IP-10 were up-regulated in liver I/R tissue in the early time, which suggested that they play an important role in liver injury induced by I/R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589091     DOI: 10.1016/j.transproceed.2007.11.076

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.